Subpotent drug: low fill volume in some of the capsules
Subpotent drug: low fill volume in some of the capsules
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Sanofi US to request your refund or repair — edit it as you like.
Subject: Recall D-841-2013 — Sanofi US Sanofi US recalls Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only Hello, I own a Sanofi US recalls Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, that is covered by recall D-841-2013 from Sanofi US. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
